Improving gene delivery and CAR T cell therapy for cancer treatment
Advanced development of composite gene delivery and CAR engineering systems
This study is working on making cancer treatments better by improving a type of therapy called CAR T cell therapy, which helps your immune system fight cancer more effectively and safely.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10929995 on NIH RePORTER |
What this research studies
This research focuses on enhancing cellular immunotherapy, specifically CAR T cell therapy, which involves engineering immune cells to target and destroy cancer cells. The project aims to develop advanced gene delivery systems and synthetic tools to improve the generation and function of therapeutic immune cells. By utilizing innovative technologies like MAJESTIC, which combines mRNA and AAV vectors, the research seeks to create more effective and safer treatments for patients with cancer. The approach includes rigorous validation to ensure that these new methods can reliably produce potent immune cells with minimal side effects.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancers that may benefit from advanced CAR T cell therapies.
Not a fit: Patients who do not have cancer or those whose cancers are not amenable to CAR T cell therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer CAR T cell therapies for cancer patients.
How similar studies have performed: Previous research has shown promise in enhancing CAR T cell therapies, but this approach aims to address specific limitations that have not been fully explored.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Chen, Sidi — Yale University
- Study coordinator: Chen, Sidi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.